Updated Jul 16, 2026
Preblick Ryan has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.36M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-10 | INDV | Indivior Pharmaceuticals, Inc. | S — Open-market sale | 36.0K | $37.70 | $1.36M |
| 2026-03-17 | INDV | Indivior Pharmaceuticals, Inc. | F — Tax withholding / forfeiture | 2.8K | $31.11 | $88K |
| 2026-03-17 | INDV | Indivior Pharmaceuticals, Inc. | M — Option exercise | 6.3K | — | |
| 2026-03-05 | INDV | Indivior Pharmaceuticals, Inc. | M — Option exercise | 86.9K | — | |
| 2026-03-05 | INDV | Indivior Pharmaceuticals, Inc. | F — Tax withholding / forfeiture | 87.6K | $31.98 | $2.80M |
| 2026-02-12 | INDV | Indivior Pharmaceuticals, Inc. | A — Grant or award | 37.4K | $0.00 |
Preblick Ryan is a corporate insider — currently tracked as Chief Financial Officer of Indivior Pharmaceuticals, Inc. (INDV). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($1.36M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Preblick Ryan profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.